Engineered human mesenchymal stem cells for neuroblastoma therapeutics

Drug-resistant neuroblastoma remains a major challenge in paediatric oncology and novel and less toxic therapeutic approaches are urgently needed to improve survival and reduce the side effects of traditional therapeutic interventions. Mesenchymal stem cells (MSCs) are an attractive candidate for ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Nieddu, Valentina, Piredda, Roberta, Bexell, Daniel, Barton, Jack, Anderson, John, Sebire, Neil, Kolluri, Krishna, Janes, Sam M., Karteris, Emmanouil, Sala, Arturo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549104/
https://www.ncbi.nlm.nih.gov/pubmed/31115546
http://dx.doi.org/10.3892/or.2019.7152

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549104/
https://www.ncbi.nlm.nih.gov/pubmed/31115546
http://dx.doi.org/10.3892/or.2019.7152

Ejemplares similares